Ageing, longevity, exceptional longevity and related genetic and non genetics markers: Panel statement

Current Vascular Pharmacology

Volumn 12, Issue 5, 2014, Pages 659-661

  Avery, Peter ^a   Barzilai, Nir ^b   Benetos, Athanase ^c   Bilianou, Helen ^d   Capri, Miriam ^e,f   Caruso, Calogero ^g   Franceschi, Claudio ^e,f   Katsiki, Niki ^h   Mikhailidis, Dimitri P ⁱ   Panotopoulos, George ^j   Sikora, Ewa ^k   Tzanetakou, Irene P ^l   Kolovou, Genovefa ^m  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^e ALMA MATER STUDIORUM ^*  (Italy)

^f CIG   (Italy)

^g UNIVERSITY OF PALERMO   (Italy)

^h ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

ⁱ ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^j Hellenic Association for the Study of Obesity Metabolism and Eating Disorders (HASOMED)   (Poland)

^k NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^l UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^m ONASSIS CARDIAC SURGERY CENTER   (Greece)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; SOMATOMEDIN C; BIOLOGICAL MARKER; GENETIC MARKER;

AGING; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; CARDIOVASCULAR DISEASE; DISABILITY; EDITORIAL; ETHNIC DIFFERENCE; EXCEPTIONAL LONGEVITY; GENETIC MARKER; HUMAN; LIFESPAN; LONGEVITY; NON GENETIC MARKER; SOCIOECONOMICS; ANIMAL; GENETICS; METABOLISM; ORGANIZATION; PHENOTYPE; TRENDS;

AGING; ANIMALS; BIOLOGICAL MARKERS; CONGRESSES AS TOPIC; GENETIC MARKERS; HUMANS; LONGEVITY; PHENOTYPE;

EID: 84924210736     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/1570161111666131219101226     Document Type: Editorial

References (9)

1. Kolovou G, Barzilai N, Caruso C, et al. The challenges in moving from ageing to successful longevity. Curr Vasc Pharmacol 2014; 12(5): 662-73.
2. Di Bona D, Accardi G, Virruso C, Candore G, Caruso C. Association between genetic variations in the insulin/insulin-like growth factor (igf-1) signalling pathway and longevity: a systematic review and meta-analysis. Curr Vasc Pharmacol 2014; 12(5): 674-81.
3. Kolovou G, Katsiki N, Pavlidis A, Bilianou H, Goumas G, Mikhailidis DP. Ageing mechanisms and associated lipid changes. Curr Vasc Pharmacol 2014; 12(5): 682-9.
4. Milman S, Atzmon G, Crandal J, Barzilai N. Phenotypes and genotypes of high density lipoprotein cholesterol in exceptional longevity. Curr Vasc Pharmacol 2014; 12(5): 690-7.
5. Sikora E, Bielak-Zmijewska A, Mosieniak G. Cellular senescence in ageing, age-related disease and longevity. Curr Vasc Pharmacol 2014; 12(5): 698-706.
6. Capri M, Santoro A, Garagnani P, et al. Genes of human longevity: an endless quest? Curr Vasc Pharmacol 2014; 12(5): 707-17.
7. Balistreri CR, Candore G, Accardi G, et al. Centenarian offspring: a model for understanding longevity. Curr Vasc Pharmacol 2014; 12(5): 718-25.
8. Tzanetakou IP, Nzietchueng R, Perrea DN, Benetos A. Telomeres and their role in aging and longevity. Curr Vasc Pharmacol 2014; 12(5): 726-34.
9. Vasto S, Barera A, Rizzo C, Di Carlo M, Caruso C, Panotopoulos G. Mediterranean diet and longevity: an example of nutraceuticals? Curr Vasc Pharmacol 2014; 12(5): 735-8.